1. Home
  2. TGL vs MBIO Comparison

TGL vs MBIO Comparison

Compare TGL & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGL

Treasure Global Inc.

HOLD

Current Price

$3.73

Market Cap

7.8M

Sector

Technology

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.79

Market Cap

7.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGL
MBIO
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
7.0M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
TGL
MBIO
Price
$3.73
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.6K
31.3K
Earning Date
02-24-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,330,557.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.53
52 Week High
$58.00
$7.00

Technical Indicators

Market Signals
Indicator
TGL
MBIO
Relative Strength Index (RSI) 37.05 39.12
Support Level $0.89 $0.53
Resistance Level $9.45 $1.00
Average True Range (ATR) 0.27 0.07
MACD -0.01 -0.01
Stochastic Oscillator 5.74 26.26

Price Performance

Historical Comparison
TGL
MBIO

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: